Cardiff Oncology, Inc. (CRDF): 4 insider purchases in the last two years (2 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jul 31, 2025 | Pace Gary W Director | 290,000 | $2.45 | $710.5K | opportunistic |
| Dec 18, 2024 | Levine James E. Officer | 7,716 | $4.76 | $36.7K | no history |
| Dec 16, 2024 | Tannenbaum Renee P Director | 10,000 | $3.42 | $34.2K | no history |
| Dec 12, 2024 | Pace Gary W Director | 361,615 | $2.60 | $940.2K | opportunistic |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.